BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32771333)

  • 1. Synchronous Malignancies Identified by
    Hoyle JM; Lenzie A; Galgano SJ; McConathy JE; Rais-Bahrami S; Nix JW; McDonald AM
    Clin Genitourin Cancer; 2021 Feb; 19(1):e37-e40. PubMed ID: 32771333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
    Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
    J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
    Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA;
    J Urol; 2019 Feb; 201(2):322-331. PubMed ID: 30179618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management.
    Marcus C; Butler P; Bagrodia A; Cole S; Subramaniam RM
    AJR Am J Roentgenol; 2020 Aug; 215(2):267-276. PubMed ID: 32551903
    [No Abstract]   [Full Text] [Related]  

  • 6. [
    Alemozaffar M; Akintayo AA; Abiodun-Ojo OA; Patil D; Saeed F; Huang Y; Osunkoya AO; Goodman MM; Sanda M; Schuster DM
    J Urol; 2020 Oct; 204(4):734-740. PubMed ID: 32347780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraprostatic Uptake of
    Robertson MS; Sakellis CG; Hyun H; Jacene HA
    AJR Am J Roentgenol; 2020 Mar; 214(3):641-648. PubMed ID: 31939697
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of
    Kim SJ; Lee SW
    Clin Radiol; 2019 Nov; 74(11):886-892. PubMed ID: 31358294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
    Fei B; Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo O; Tade F; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Schuster DM
    J Urol; 2019 Aug; 202(2):413-421. PubMed ID: 30817240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of
    Wang Y; Chow DZ; Ebert E; Tajmir S; Scott JA; Palmer EL
    AJR Am J Roentgenol; 2020 Oct; 215(4):997-1001. PubMed ID: 32569513
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluciclovine, Anti-1-Amino-3-[
    Nguyen QD; Amato R; Riascos R; Ballester L; Tandon N; Blanco A; Esquenazi Y
    World Neurosurg; 2018 Nov; 119():132-136. PubMed ID: 30077749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of
    Scarsbrook AF; Bottomley D; Teoh EJ; Bradley KM; Payne H; Afaq A; Bomanji J; van As N; Chua S; Hoskin P; Chambers A; Cook GJ; Warbey VS; Han S; Leung HY; Chau A; Miller MP; Gleeson FV;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):316-324. PubMed ID: 32068113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
    Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of Prostate Cancer Using Fluciclovine.
    Savir-Baruch B; Zanoni L; Schuster DM
    PET Clin; 2017 Apr; 12(2):145-157. PubMed ID: 28267449
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Rais-Bahrami S; Efstathiou JA; Turnbull CM; Camper SB; Kenwright A; Schuster DM; Scarsbrook AF
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):997-1006. PubMed ID: 34012062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of
    Gusman M; Aminsharifi JA; Peacock JG; Anderson SB; Clemenshaw MN; Banks KP
    Radiographics; 2019; 39(3):822-841. PubMed ID: 31059396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best Practices for
    Tade FI; Sajdak RA; Gabriel M; Wagner RH; Savir-Baruch B
    J Nucl Med Technol; 2019 Dec; 47(4):282-287. PubMed ID: 31182661
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.
    Chau A; Gardiner P; Colletti PM; Jadvar H
    Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
    Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.